Possible side effects include injection-site reactions, temporary skin irritation from topical use, and in rare cases, the "copper uglies" phenomenon
What we do know: GHK-Cu is a naturally occurring peptide already present in your body
Whilst retatrutide targets GLP-1, GIP, and glucagon receptors to reduce appetite and increase energy expenditure, cagrilintide acts via the amylin receptor pathway a distinct hormonal axis
It cannot be used directly for FDA new drug applications
Because the body spews free radicals when it uses oxygen, the brain is awash in rogue molecules
Contact the MetwareBio team to discuss sample type, stabilization requirements, quantitative goals, and a study-specific analytical workflow